Nath Bio-Genes (India) Limited (NATHBIOGEN) — Cash Flow Quality Index
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Cash Flow Quality Index of -2.71x as of September 2025. Operating cash flow of Rs-1.09 Billion is below net income of Rs400.34 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NATHBIOGEN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nath Bio-Genes (India) Limited Cash Flow Quality Index (2013–2026)
Historical Cash Flow Quality Index for Nath Bio-Genes (India) Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Nath Bio-Genes (India) Limited (NATHBIOGEN) cash flow conversion.
Annual Cash Flow Quality Index for Nath Bio-Genes (India) Limited (2013–2026)
Year-by-year earnings quality comparison for Nath Bio-Genes (India) Limited.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | -0.53x | Rs-220.35 Million | Rs416.30 Million | ▼ -216.2% |
| 2025 | 0.46x | Rs175.81 Million | Rs386.00 Million | ▼ -73.2% |
| 2024 | 1.70x | Rs614.80 Million | Rs361.70 Million | ▲ +60.2% |
| 2023 | 1.06x | Rs383.67 Million | Rs361.64 Million | ▲ +5310.2% |
| 2021 | 0.02x | Rs11.13 Million | Rs567.51 Million | ▼ -90.0% |
| 2020 | 0.20x | Rs94.74 Million | Rs485.08 Million | ▲ +134.5% |
| 2019 | -0.57x | Rs-219.89 Million | Rs388.68 Million | ▲ +63.8% |
| 2018 | -1.56x | Rs-469.84 Million | Rs300.54 Million | ▼ -883.3% |
| 2017 | 0.20x | Rs33.43 Million | Rs167.53 Million | ▲ +121.5% |
| 2016 | -0.93x | Rs-141.68 Million | Rs152.34 Million | ▼ -462.8% |
| 2015 | 0.26x | Rs67.55 Million | Rs263.53 Million | ▼ -56.5% |
| 2014 | 0.59x | Rs150.28 Million | Rs255.13 Million | ▼ -49.0% |
| 2013 | 1.16x | Rs142.11 Million | Rs122.96 Million | — |